In this issue:

• The trouble with being a cure-all Its reputation as a panacea creates product liability concerns for the stem cell
• Which product-safety data is admissible? Depending on the situation, such evidence can be either crucial or unreliable
• Pennsylvania wrestling anew with an old question: venue What happens if a ban on venue-shopping in medical malpractice cases is eliminated?
• Why electronic cigarettes are the next mass tort What you need to know about e-cigs—and why they’re the next mass tort

Read the latest Product Liability Playbook here.

The Product Liability Playbook is a collaborative effort of Goldberg Segalla’s Product Liability practice examining the latest practices, emerging developments, and influential court decisions in product liability law.